Cargando…
Psychiatrist-led treatment of hepatitis C (HCV) at an opioid agonist treatment (OAT) clinic in Stockholm - enhancing the HCV treatment care cascade
INTRODUCTION: People who inject drugs (PWID) and opioid agonist treatment (OAT) patients have an increased hepatitis C (HCV) prevalence. Studies among these populations show promising HCV treatment results, which is essential to reach the WHO goal of eliminating HCV as a major public health threat b...
Autores principales: | Kåberg, M., Klasa, P.-E., Nordin, T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9563151/ http://dx.doi.org/10.1192/j.eurpsy.2022.468 |
Ejemplares similares
-
1483. Real-time Creation of HCV Treatment Cascades in Clinics to Improve HCV Treatment Rates Among Patients with HIV/HCV Co-infection
por: Wegener, Maximilian D, et al.
Publicado: (2023) -
Optimizing Hepatitis C Virus (HCV) Treatment in a US Colocated HCV/Opioid Agonist Therapy Program
por: Habchi, Jackie, et al.
Publicado: (2020) -
2494. Massachusetts HCV Treatment Report Card: Hepatitis C Virus Care Cascade for Women of Reproductive Age with Opioid Use Disorder, 2014-2020
por: Epstein, Rachel L, et al.
Publicado: (2023) -
932. Creating a Statewide HCV Treatment Cascade for HIV/HCV Co-Infected Persons Using a Partnership with DPH
por: Wegener, Maximilian D, et al.
Publicado: (2020) -
Insights on the Russian HCV care cascade: minimal HCV treatment for HIV/HCV co-infected PWID in St. Petersburg
por: Tsui, Judith I., et al.
Publicado: (2016)